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Abstract. A series of novel amino acid ureidoamides 4a-o were prepared from N-(1-benzotriazole-
carbonyl)-amino acid chloride 3, derived from L-alanine, L-valine, L-leucine, D-phenylglycine and  
L-phenylalanine, and the corresponding aminoalcohols (2-amino-1-ethanol, 3-amino-1-propanol and  
5-amino-1-pentanol). The compounds were fully characterized by standard spectroscopic methods (IR, 1H 
and 13C NMR) and their structure was confirmed by elemental analysis. Antioxidant screenings (interac-
tion with 1,1-diphenyl-2-picrylhydrazyl, soybean lipoxygenase inhibition activity, inhibition of linoleic 
acid lipid peroxidation) revealed that the prepared compounds possessed only modest activity. On the 
other hand, no significant antiproliferative activity against five human cell lines and very weak antimicro-
bial activity against several bacteria and fungi were detected.  
Keywords: urea, amide, amino acid, benzotriazole, hydantoin, hydroxylamine, antioxidant activity  
 
INTRODUCTION 
Benzotriazole is a very useful synthetic auxiliary with 
versatile applications in organic chemistry. Since 1985, 
Katritzky and collaborators have published more than 
300 papers and several reviews dealing with benzotria-
zole.1–7 Our group started benzotriazole chemistry re-
search in 1977 and the results have been published in 
approximately 30 papers.8–11 We have used benzotria-
zole in the synthesis of various heterocyclic compounds 
(benzoxazine, quinazoline, triazinetrione, hydantoin and 
oxadiazine derivatives), amino acid derivatives, poly-
mer-drug and thiomer-drug conjugates, carbamates, 
ureas, semicarbazides, carbazides, sulfonylureas, sul-
fonylcarbazides, nitroalkanic acid esters, hydantoic 
acids, etc. This paper is a continuation of two previous 
papers dealing with hydroxyurea derived from amino 
acid amides bearing benzotriazole moiety.12,13 Some of 
the synthesized hydroxyureas showed significant cy-
tostatic activity and we found it worth preparing a series 
of analogue compounds with hydroxyl group detached 
from urea nitrogen with two or more methylene spacers. 
Their synthesis and preliminary biological screening are 
reported herein.  
 
EXPERIMENTAL 
Materials and Methods 
Melting points were determined on a Stuart SMP 3 
melting apparatus and were uncorrected. IR spectra 
(νmax /cm–1) were recorded on a FTIR Perkin Elmer 
Paragon 500 spectrometer and UV/VIS spectra on a 
Varian Cary 100Bio UV-visible spectrometer. 1H and 
13C NMR spectra were taken on a Varian Gemini 300 
spectrometer, operating at 300 and 75.5 MHz for the 1H 
and 13C nuclei, respectively. Samples were measured in 
DMSO-d6 solutions at 20 ºC in 5 mm NMR tubes. Che-
mical shifts ( /ppm) were referred to TMS. Precoated 
silica gel 60 F254 plates were used for thin-layer chro-
matography. Solvent systems were CH2Cl2 /MeOH  
(9:1 and 4:1). Spots were visualized by phosphomolyb-
dic acid. Column chromatography was performed on 
silica gel (0.063–0.200 mm) with CH2Cl2 /MeOH (9:1, 
8.5:1.5 and 4:1) and CHCl3 /MeOH = 9.5:0.5 as eluents. 
Amino acids (L-alanine, L-valine, L-leucine,  
D-phenylglycine and L-phenylalanine) were purchased 
from Kemika (Croatia), and amines (2-amino-1-etha-
nol, 3-amino-1-propanol, 5-amino-1-pentanol, hydro-
xylamine, O-benzylhydroxylamine and triethylamine
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(TEA)) from Sigma-Aldrich (USA). 1-Benzotriazole 
carboxylic acid chloride (1), N-(1-benzotriazolecarbo-
nyl)-amino acids 2 and chlorides 3 were prepared ac-
cording to previously published procedures.8,14–16 
 
Ureido Derivatives 4a-o. General Procedure 
A mixture of N-(1-benzotriazolecarbonyl)-amino acid 
chloride (3a-e) (1 mmol) and an appropriate amine 
(3 mmol) in 10 mL of dry dioxane was stirred at room 
temperature for 24 h and evaporated. Crude product  
4a-o was purified by column chromatography and  
then triturated or recrystallized using the solvents given 
below. 
 
1-(1-(2-Hydroxyethylcarbamoyl)ethyl)-3-(2-hydroxy-
ethyl)urea 4a 
Crude product 4a was purified by column chroma-
tography (eluent CH2Cl2 /MeOH = 8.5:1.5→4:1) and 
triturated with Et2O. Yield: 0.132 g (61 %); m.p. 150–
154 ºC; IR (KBr) νmax /cm–1: 3422, 3274, 2969, 2937, 
2879, 1644, 1570, 1056.  
Anal. Calcd. mass fractions of elements, w /%, for 
C8H17N3O4 (Mr = 219.24) are: C 43.83, H 7.82, N 19.17; 
found: C 43.93, H 7.73, N 19.05. 
 
1-(1-(3-Hydroxypropylcarbamoyl)ethyl)-3-(3-hydroxy-
propyl)urea 4b 
Crude product 4b was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 4:1) and triturated with 
Et2O. Yield: 0.139 g (56 %); m.p. 152–156 ºC; IR 
(KBr) νmax /cm–1: 3345, 3275, 2941, 2875, 1638, 1560, 
1060.  
Anal. Calcd. mass fractions of elements, w /%, for 
C10H21N3O4 (Mr = 247.29) are: C 48.57, H 8.56, N 16.99; 
found: C 48.35, H 8.77, N 16.84. 
 
1-(1-(5-Hydroxypentylcarbamoyl)ethyl)-3-(5-hydroxy-
pentyl)urea 4c 
Crude product 4c was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 4:1) and triturated with 
Et2O. Yield: 0.180 g (59 %); m.p. 142–146 ºC; IR (KBr) 
νmax /cm–1: 3360, 3282, 3111, 2936, 2862, 1627, 1561, 
1056.  
Anal. Calcd. mass fractions of elements, w /%, for 
C14H29N3O4 (Mr = 303.40) are: C 55.42, H 9.63, N 13.8; 
found: C 55.62, H 9.47, N 14.02. 
 
1-(1-(2-Hydroxyethylcarbamoyl)-2-methylpropyl)-3-(2-
hydroxyethyl)urea 4d 
Crude product 4d was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 8.5:1.5→4:1) and recrys-
tallized from MeOH/Et2O. Yield: 0.140 g (57 %); m.p. 
194–198 ºC; IR (KBr) νmax /cm–1: 3351, 3280, 3102, 
2969, 2874, 1626, 1571, 1063.  
Anal. Calcd. mass fractions of elements, w /%, for 
C10H21N3O4 (Mr = 247.29) are: C 48.57, H 8.56, N 16.99; 
found: C 48.88, H 8.53, N 16.61. 
1-(1-(3-Hydroxypropylcarbamoyl)-2-methylpropyl)-3-
(3-hydroxypropyl)urea 4e 
Crude product 4e was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 9:1→4:1) and recrystal-
lized from MeOH/Et2O. Yield: 0.154 g (56 %); m.p. 
178–181 ºC; IR (KBr) νmax /cm–1: 3350, 3279, 3102, 
2963, 2874, 1630, 1566, 1234, 1078, 1044.  
Anal. Calcd. mass fractions of elements, w /%, for 
C12H25N3O4 (Mr = 275.34) are: C 52.34, H 79.15, N 15.26; 
found: C 52.53, H 9.01, N 15.44. 
 
1-(1-(5-Hydroxypentylcarbamoyl)-2-methylpropyl)-3-
(5-hydroxypentyl)urea 4f 
Crude product 4f was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 9:1→4:1) and triturated 
with Et2O. Yield: 0.171 g (52 %); m.p. 159–162 ºC; IR 
(KBr) νmax /cm–1: 3349, 3278, 3107, 2935, 2861, 1628, 
1572, 1236, 1059.  
Anal. Calcd. mass fractions of elements, w /%, for 
C16H33N3O (Mr = 331.45) are: C 57.98, H 10.04, N 12.68; 
found: C 57.75, H 10.17, N 12.93. 
 
1-(1-(2-Hydroxyethylcarbamoyl)-3-methylbutyl)-3-(2-
hydroxyethyl)urea 4g 
Crude product 4g was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 8.5:1.5). Yield: 0.138 g 
(53 %); m.p. 157–161 ºC; IR (KBr) νmax /cm–1: 3354, 
3290, 3098, 2954, 2928, 2872, 1625, 1569, 1059.  
Anal. Calcd. mass fractions of elements, w /%, for 
C11H23N3O4 (Mr = 261.32) are: C 50.56, H 8.87, N 16.08; 
found: C 50.56, H 8.87, N 16.08. 
 
1-(1-(3-Hydroxypropylcarbamoyl)-3-methylbutyl)-3-(3-
hydroxypropyl)urea 4h 
Crude product 4h was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 8.5:1.5) and triturated 
with Et2O. Yield: 0.150 g (52 %); m.p. 109–111 ºC; IR 
(KBr) νmax /cm–1: 3351, 3308, 3098, 2957, 2872, 1630, 
1572, 1252, 1073.  
Anal. Calcd. mass fractions of elements, w /%, for 
C13H27N3O4 (Mr = 289.37) are: C 53.96, H 9.40, N 14.52; 
found: C 53.69, H 9.23, N 14.79. 
 
1-(1-(5-Hydroxypentylcarbamoyl)-3-methylbutyl)-3-(5-
hydroxypentyl)urea 4i 
Crude product 4i was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 9:1→8.5:1.5) and tritu-
rated with Et2O. Yield: 0.270 g (78 %); m.p. 83–86 ºC; 
IR (KBr) νmax /cm–1: 3349, 3280, 3100, 2937, 2862, 
1626, 1562, 1262, 1059.  
Anal. Calcd. mass fractions of elements, w /%, for 
C17H35N3O4 (Mr = 345.48) are: C 59.10, H 10.21, N 12.16; 
found: C 59.30, H 10.11, N 12.19. 
 
1-((2-Hydroxyethylcarbamoyl)(phenyl)methyl)-3-(2-
hydroxyethyl)urea 4j 
Crude product 4j was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 8.5:1.5→4:1) and tritu-
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rated with Et2O. Yield: 0.171 g (61 %); m.p. 206–208 
ºC; IR (KBr) νmax /cm–1: 3422, 3274, 2969, 2937, 2879, 
1644, 1570, 1056.  
Anal. Calcd. mass fractions of elements, w /%, for 
C13H19N3O4 (Mr = 281.31) are: C 55.50, H 6.81, N 14.94; 
found: C 55.78, H 6.57, N 14.77. 
 
1-((3-Hydroxypropylcarbamoyl)(phenyl)methyl)-3-(3-
hydroxypropyl)urea 4k 
Crude product 4k was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 8.5:1.5) and recrystallized 
from MeOH/Et2O. Yield: 0.170 g (55 %); m.p. 182–
185 ºC; IR (KBr) νmax /cm–1: 3354, 3289, 3092, 2942, 
2883, 1626, 1561, 1059.  
Anal. Calcd. mass fractions of elements, w /%, for 
C15H23N3O4 (Mr = 309.36) are: C 58.24, H 7.49, N 13.58; 
found: C 58.37, H 7.26, N 13.73. 
 
1-((5-Hydroxypentylcarbamoyl)(phenyl)methyl)-3-(5-
hydroxypentyl)urea 4l 
Crude product 4l was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 8.5:1.5) and recrystallized 
from MeOH/Et2O. Yield: 0.222 g (61 %); m.p. 178–
180 ºC; IR (KBr) νmax /cm–1: 3362, 3286, 3093, 2937, 
2861, 1628, 1564, 1352, 1061.  
Anal. Calcd. mass fractions of elements, w /%, for 
C19H31N3O4 (Mr = 365.47) are: C 62.44, H 8.55, N 11.50; 
found: C 62.65, H 8.71, N 11.69. 
 
1-(1-(2-Hydroxyethylcarbamoyl)-2-phenylethyl)-3-(2-
hydroxyethyl)urea 4m 
Crude product 4m was purified by column chromatog-
raphy (eluent CH2Cl2 /MeOH = 8.5:1.5). Yield: 0.230 g 
(78 %); m.p. 140–143 ºC; IR (KBr) νmax /cm–1: 3377, 
3310, 3105, 2937, 2876, 1626, 1569, 1496, 1231, 1056.  
Anal. Calcd. mass fractions of elements, w /%, for 
C14H21N3O4 (Mr = 295.33) are: C 56.94, H 7.17, N 14.23; 
found: C 56.69, H 7.32, N 14.44. 
 
1-(1-(3-Hydroxypropylcarbamoyl)-2-phenylethyl)-3-(3-
hydroxypropyl)urea 4n 
Crude product 4n was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 8.5:1.5). Yield: 0.243 g 
(75 %); m.p. 110–113 ºC; IR (KBr) νmax /cm–1: 3358, 
3280, 3106, 2942, 2878, 1628, 1564, 1235, 1050.  
Anal. Calcd. mass fractions of elements, w /%, for 
C16H25N3O4 (Mr = 323.39) are: C 59.42, H 7.79, N 12.99; 
found: C 59.38, H 7.88, N 12.75. 
 
1-(1-(5-Hydroxypentylcarbamoyl)-2-phenylethyl)-3-(5-
hydroxypentyl)urea 4o 
Crude product 4o was purified by column chromatogra-
phy (eluent CH2Cl2 /MeOH = 9:1) and trituration with 
Et2O. Yield: 0.197 g (52 %); m.p. 89–93 ºC; IR (KBr) 
νmax /cm–1: 3362, 3282, 3106, 2931, 2859, 1626, 1559, 
1236, 1060.  
Anal. Calcd. mass fractions of elements, w /%, for 
C20H33N3O4 (Mr = 379.49) are: C 63.30, H 8.76, N 11.07; 
found: C 63.45, H 8.92, N 11.31. 
 
N-(1-benzotriazolecarbonyl)-L-alanine N-hydroxy-
amide 5a 
A solution of 0.339 g (1 mmol) N-(1-benzotriazole-
carbonyl)-L-alanine O-benzyloxyamide (8a) in 20 mL 
MeOH was hydrogenolyzed using 50 mg Pd/C as a 
catalyst. After 2.5 h the reaction mixture was filtered, 
evaporated and the thus obtained crude product was 
triturated with Et2O and filtered off. Yield: 0.231 g (93 
%). IR (KBr) νmax /cm–1: 3613, 3225, 3079, 1714, 1694, 
1657, 1523, 1068, 843, 772.  
Anal. Calcd. mass fractions of elements, w /%, for 
C10H11N5O3 (Mr = 249.23) are: C 48.19, H 4.45, N 28.10; 
found: C 48.45, H 4.72, N 28.46; 1H NMR (DMSO-d6)  10.81 (s, 1H, OH), 9.09−9.06 (d, 1H, NCONH), 8.94 
(s, 1H, NHO), 8.23−7.53 (m, 4H, arom.), 4.46−4.37  
(q, 1H, CH), 1.48−1.45 (d, 3H, CH3); 13C NMR 
(DMSO-d6)  168.58 (CO amide), 149.04 (CO urea), 
145.90−113.99 (arom.), 48.56 (CH), 18.39 (CH3). 
 
3-Hydroxyhydantoins 6 
3-Hydroxy-5-methylhydantoin 6a 
To a solution of 0.249 g (1 mmol) N-(1-benzotriazole-
carbonyl)-L-alanine N-hydroxyamide (5a) in acetone 
(40 mL), 5 % Na2CO3 solution (4 mL) was added.17 The 
reaction mixture was stirred at r.t. for 2 h. Acetone was 
evaporated in vacuo and the precipitated product 6a was 
filtered off, washed with water and recrystallized from 
acetone and water. Analytical data of compound 6a are 
consistent with the literature data.18 
 
3-Hydroxy-5-benzylhydantoin 6b 
A solution of 0.207 g (0.7 mmol) of 3-benzyloxy-5-
benzylhydantoin (9b) in 30 mL MeOH was hydro-
genolyzed using 50 mg Pd/C as a catalyst. After 2.5 h 
the reaction mixture was filtered, methanol was evapo-
rated and the thus obtained crude product was triturated 
with Et2O. Yield: 0.086 g (60 %). Analytical data of 
compound 6b are consistent with the literature data.18 
 
N-(1-benzotriazolecarbonyl)-L-amino acid O-benzyl-
oxyamides 8. General Procedure 
A solution of 2.5 mmol N-(1-benzotriazolecarbonyl)-L-
amino acid 2 in 10 mL SOCl2 was stirred at room tem-
perature and evaporated after 24 h. Crude chloride 3 
was dissolved in 20 mL toluene and cooled to 0 C. A 
mixture of 0.308 g (2.5 mmol) O-benzylhydroxylamine 
and 0.253 g (2.5 mmol) TEA in 25 mL toluene was 
added dropwise. The reaction mixture was stirred on an 
ice bath for 1 h, extracted several times with water, 
dried over sodium sulphate and evaporated. 
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N-(1-benzotriazolecarbonyl)-L-alanine O-benzyloxy-
amide 8a 
Crude product 8a was triturated with Et2O and filtered 
off. Yield: 0.474 g (56 %). The sample for analysis was 
recrystallized from toluene. IR (KBr) νmax /cm–1: 3414, 
3357, 3224, 1719, 1671, 1530, 1449, 1231, 1058, 756, 
696.  
Anal. Calcd. mass fractions of elements, w /%, for 
C17H17N5O3 (Mr = 339.13) are: C 60.17, H 5.05, N 20.64; 
found: C 60.38, H 5.32, N 20.31; 13C NMR (DMSO-d6)  169.73 (CONH), 153.06 (NCONH), 134.06−125.66 
(arom.), 78.81 (OCH2), 50.39 (CH), 17.38 (CH3).  
N-(1-benzotriazolecarbonyl)-L-phenylalanine O-benzyl-
oxyamide 8b 
Crude product 8b was purified by column chromatogra-
phy (eluent CHCl3/MeOH = 9.5:0.5) and recrystallized 
from Et2O/petrolether. Yield: 0.353 g (34 %); IR (KBr) 
νmax /cm–1: 3370, 3173, 2971, 1743, 1697, 1674, 1508, 
1448, 1048, 756, 701.  
Anal. Calcd. mass fractions of elements, w /%, for 
C23H21N5O3 (Mr = 415.44) are: C 66.49, H 5.09, N 16.86; 
found: C 66.45, H 4.92, N 16.51; 13C NMR (DMSO-d6)  168.44 (CONH), 153.28 (NCONH), 135.64−127.65 
(arom.), 79.17 (OCH2), 55.71 (CH), 37.10 (CH2). 
 
3-Benzyloxyhydantoins 9. General Procedure 
A solution of 2 mmol N-(1-benzotriazolecarbonyl)-L-
amino acid 2 in 10 mL SOCl2 was stirred at room tem-
perature and evaporated after 24 h. Crude chloride 3 
was dissolved in 20 mL toluene. A mixture of 0.246 g  
(2 mmol) O-benzylhydroxylamine and 0.202 g (2 mmol) 
TEA in 20 mL toluene was added. The reaction mixture 
was stirred at r.t. for 5 h, extracted several times with 
5 % NaOH solution, then with water, dried over sodium 
sulphate and evaporated. 
 
3-Benzyloxy-5-i-butylhydantoin 9a 
Crude product 9a was triturated with Et2O and filtered 
off. Yield: 0.428 g (82 %). The sample for analysis was 
recrystallized from toluene. Analytical data of com-
pound 9a are consistent with the literature data.19 
 
3-Benzyloxy-5-benzylhydantoin 9b 
Crude product 9b was triturated with Et2O, filtered off 
and recrystallized from toluene. Yield: 0.255 g (43 %). 
IR (KBr) νmax /cm–1: 3244, 1783, 1728, 1425, 1214, 748, 
724, 696.  
Anal. Calcd. mass fractions of elements, w /%, for 
C17H16N2O3 (Mr = 296.32) are: C 68.91, H 5.44, N 9.45; 
found: C 68.55 H 5.62, N 9.31. 1H NMR (DMSO-d6)  
8.44 (s, 1H, NH), 7.40–7.19 (m, 10H, arom.), 
4.73−4.64 (dd, 2H, OCH2), 4.42 (t, 1H, CH), 2.99–2.97 
(d, 2H, CH2); 13C NMR (DMSO-d6)  168.13 (CO), 
152.96 (CO), 135.27−127.37 (arom.), 78.85 (OCH2), 
55.38 (CH), 36.73 (CH2). 
Biological Evaluation 
 
General Experimental Details 
Each experiment in vitro was performed at least in  
triplicate and the standard deviation of absorbance  
was less than 10 % of the mean. 1,1-Diphenyl-picryl-
hydrazyl (DPPH), 2,2'-azobis(2-amidinopropane) dihy-
drochloride (AAPH), nordihydroguaiaretic acid (NDGA), 
sodium linoleate, soybean lipoxygenase (LO), caffeic 
acid and Trolox were purchased from Aldrich-Sigma 
(USA). All the tested compounds were dissolved in 
DMSO. 
 
Interaction with DPPH Activity 20 
To a solution of DPPH (c = 0.05 mmol dm–3) in abso-
lute ethanol, an equal volume of ethanolic solution of 
the tested compound (c = 0.1 or 0.05 mmol dm–3) was 
added. After 20 and 60 min, the absorbance was re-
corded at 517 nm and compared with the appropriate 
standard NDGA. Ethanol was used as a control. 
 
Soybean Lipoxygenase Inhibition Activity 
DMSO solution of the tested compound was incubated 
with sodium linoleate (c = 0.1 mmol dm–3) and 0.2 mL 
of soybean lipoxygenase solution (1/9 × 10–4 w/v  
in saline) at room temperature. Conversion of sodium 
linoleate to 13-hydroperoxylinoleic acid was recorded  
at 234 nm and compared with the standard inhibitor 
caffeic acid, according to the procedure previously  
reported.20 
 
Inhibition of Linoleic Acid Lipid Peroxidation21 
Peroxidation of linoleic acid to conjugated diene hy-
droperoxide in an aqueous dispersion was monitored at 
234 nm. AAPH was used as a free radical initiator. Ten 
microliters of linoleic acid dispersion (c = 16 mmol dm–3) 
was added to the UV cuvette containing 0.93 mL phos-
phate buffer (c = 0.05 mmol dm–3), pH = 7.4, prether-
mostated at 37 °C. The oxidation reaction was initiated 
at 37 °C under air by adding 50 μL of AAPH solution  
(c = 40 mmol dm–3). Oxidation was carried out in the 
presence of the tested compounds (10 μL, final concen-
tration 0.1 mmol dm–3). In the assay with no antioxi-
dant, lipid peroxidation was measured in the presence of 
the same level of DMSO. The rate of oxidation was 
monitored at 37 °C by recording the increase of absorp-
tion at 234 nm caused by conjugated diene hydroperox-
ides. The results were compared to the standard inhibi-
tor Trolox. 
 
Cytostatic Activity Assays 
Cytostatic activity against five human cell lines, derived 
from 4 cancer types, was measured as described previ-
ously.17 The following cell lines were used: MCF-7 
(breast carcinoma), SW 620 (colon carcinoma), HCT 
116 (colon carcinoma), MOLT-4 (acute lymphoblastic 
leukaemia) and H 460 (lung carcinoma). 
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Antimicrobial Activity 
Microbial species (Bacillus subtilis ATCC 6633, 
Staphylococcus aureus ATCC 25923, Escherichia coli 
ATCC 10536, Pseudomonas aeruginosa ATCC 27853, 
Candida albicans ATCC 10231 and Aspergilus niger 
ATCC 16404) used in the study were obtained from the 
American Type Culture Collection, LGC Promochem, 
UK. Trypticasa soy agar and Müller-Hinton agar were 
purchased from Merck (Germany), Sabouraud 2 % 
(m/V)-glucose agar from BBL (Germany), amphotericin 
B from Sigma and norfloxacin from Krka (Slovenia). 
RESULTS AND DISCUSSION 
Chemistry 
New ureidoamides 4a-o, derivatives of amino acids, 
were prepared from N-(1-benzotriazolecarbonyl)-amino 
acid chlorides 3a-e and the corresponding aminoalco-
hols. Synthesis of analogous ureidoamides with various 
monofunctional amines or N-hydroxyurea amides was 
previously described by us,12,13,16 as well as the synthe-
sis of the starting compounds 1-benzotriazolecarboxy- 
lic acid chloride (1)8,14 and N-(1-benzotriazolecarbonyl)-
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Scheme 1. Synthesis of ureidoamides 4a-o. 
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amino acids (2).15 The optimal molar ratio of aminoal-
cohol to chloride 3 was 3:1. Amino groups selectively 
reacted with 2-amino-1-ethanol, 3-amino-1-propanol 
and 5-amino-1-pentanol and the reaction products were 
ureidoamides 4 (Scheme 1). 
However, when hydroxylamine was used as  
aminoalcohol, a mixture of products was obtained.  
N-hydroxyureido hydroxamic acids of the general  
formula 7 were obtained only in traces, while the main 
products were 3-hydroxyhydantoins 6, obtained by 
cyclization of N-(1-benzotriazolecarbonyl)-L-amino acid 
N-hydroxyamides 5. Compounds 5 could be obtained  
in quantitative yield by catalytic hydrogenation of  
N-(1-benzotriazolecarbonyl)-L-amino acid O-benzyloxy-
amides 8. L-alanine and L-phenylalanine derivatives 8a 
and 8b were isolated in the reaction of the correspond-
ing chlorides 3 with O-benzylhydroxylamine, while  
L-leucine derivative 8c spontaneously cyclized to  
3-benzyloxyhydantoin 9a. Phenylalanine hydantoin 9b 
was also prepared directly from chloride 3, without 
isolation of amide 8b, when the reaction time was pro-
longed. Hydantoins 9 were readily hydrogenated to  
3-hydroxyhydantoins 6. Compounds 6 could be obtained 
by cyclization of amide 5 in alkaline medium as well.17 
In our previous research, reactions of chlorides 3 
with N-phenylhydroxylamine afforded hydroxamic 
acids 10, which readily cyclized to 1,2,5-oxadiazine 
derivatives 11 under basic conditions.22 In that case, 
hydroxamic acids 10 could be successfully isolated. 
Scheme II depicts the reactions of amino acid deriva-
tives with hydroxylamines. 
To obtain compounds with different physico-
chemical properties, amino acids with both aliphatic  
(L-alanine, L-valine and L-leucine) and aromatic  
(D-phenylglycine and L-phenylalanine) residues were 
used. Structures of compounds 4a-o were deduced from 
analyses of their IR, 1H and 13C NMR spectra and were 
confirmed by elemental analysis. The chemical shifts 
were consistent with the proposed structures of the 
novel compounds (Table1). IR spectra of ureidoamides 
4a-o showed characteristic bands at 3422–3345 (OH), 
3310–3100 (NH), 1644–1625 (amide and urea carbon-
yls) and 1572–1559 (amide II) cm–1. In 1H NMR spec-
tra, amide NH (1') in all aliphatic amino acid and 
phenylalanine derivatives showed as triplets between 
7.90 and 7.84 ppm, while in phenylglycine derivati- 
ves 4j-l it was slightly shifted downfield (8.31–8.26 
ppm). Ureido NH (3) showed as doublets between 6.21 
Table 2. Interaction with DPPH, in vitro inhibition of soybean lipoxygenase (LO) and lipid peroxidation (LP). All values are 
expressed in percents 
Compound DPPH 20 min(a) 
DPPH 
60 min(a) 
DPPH 
20 min(b) 
DPPH 
60 min(b) LO inhibition
(b) LP inhibition(b) 
4a 1.7 0.5 n.a.(c) n.a. 28.1 n.a. 
4b n.a. 0.9 0.3 1 49.5(d) 32.9 
4c 3.2 3.9 1.4 4.8 22.6 94.6 
4d 3.4 6.3 2.1 3.5 55.7(d) 24.2 
4e 2.7 6.3 5.0 4.7 37.8 15.0 
4f n.a. 1.2 2.3 5.2 36.1 43.7 
4g 1.2 0.9 n.a. 1.5 52.8(d) 59.6 
4h n.a. 3.2 0.9 3.6 42.6 16.1 
4i 1.2 1.1 2.7 2.8 42.5 11.1 
4j 2.3 3.8 5.7 7.5 50.1(d) 63.1 
4k n.a. 2.2 4.9 1.3 55.6(d) 47.9 
4l 1.6 2.4 0.9 3.7 36.9 3.9 
4m 0.5 3.0 n.a. 1.1 49.2(d) 87.4 
4n 0.9 1.8 n.a. 0.9 39.7 19.9 
4o 1.8 3.3 2.5 3.7 27.6 16.6 
Caffeic acid n.d.(e) n.d. n.d. n.d. 600 n.d. 
NDGA 81 83 93 97 n.d. n.d. 
Trolox n.d. n.d. n.d. n.d. n.d. 63 
Concentrations of the tested compounds: 
(a) 5 × 105 mol dm–3. 
(b) 1 × 104 mol dm3. 
(c) n.a.  no activity under the reported experimental conditions. 
(d) IC50 value was also determined: 100 (4b), 92.5 (4d), 98 (4g), 100 (4j), 88 (4k), 100 (4m) μmol dm–3. 
(e) n.d.  not determined. 
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and 5.88 ppm, except in phenylglycine derivatives 
(6.78−6.60 ppm). Ureido NH (1') appeared as triplets 
between 6.14 and 6.01 ppm. Signals from phenylglycine 
derivatives were again slightly shifted to 6.29–6.21. 
Hydroxyl groups appeared as one or two superimposed 
triplets between 4.68 and 4.32 (ppm values decreased 
with the length of the chain). All three NH groups and 
OH were exchangeable with D2O. Amide carbonyl 
group (1) in 13C NMR spectra appeared between 173.78 
and 172.06, except in phenylglycine derivatives 
(171.25–170.96), while ureido carbonyl was uniformly 
located between 158.45 and 157.49 ppm. 
 
Biological Activity 
Newly synthesized ureidoamides 4a-o were screened for 
antioxidative, antimicrobial and cytostatic activities. 
The results have shown that biological activity of the 
tested compounds was rather modest. 
Interaction of the tested compounds with the free 
radical DPPH was very weak (Table 2). The results 
were below 10 % and no increase was observed with the 
increase of ureidoamide concentration (0.05 mmol dm–3 
and 0.1 mmol dm–3) and the time of interaction (20 min 
and 60 min). Soybean lipoxygenase inhibition activity 
assay showed that the tested ureidoamides were modest 
LO inhibitors (Table 2). IC50 values for compounds 4b, 
4d, 4g, 4j, 4k, 4m were between 92.5 and 100 μmol dm–3, 
while the percent of inhibition for the other compounds 
ranged from 22.6 to 42.6 % at the concentration  
c = 1 × 10–4 mol dm–3. Most of the tested compounds 
exerted no significant inhibition of lipid peroxidation, 
with the exception of compounds 4c and 4m, followed 
by 4g and 4j (Table 2). From the results it was not possible 
to delineate the influence of certain structural characteris-
tics and physicochemical properties in terms of (Q)SAR. 
Evaluation of cytostatic activities against malig-
nant tumor cell lines has shown that ureidoamides 4a-o 
possess very weak antiproliferative activity (data not 
shown), significantly lower than the urea amides with 
hydroxyl group directly attached to urea nitrogen.12,13  
Results of microbiological screening using the 
hole-plate diffusion method23 revealed that ureido-
amides 4a-o showed no growth inhibition zones,  
and were considered inactive at the concentration used 
(data not shown). The minimum inhibitory (MIC) and 
minimum microbicidal concentrations (MMcC) were 
determined by the microdilution broth method.24 
MIC/MMcC values were high (data not shown). The 
strongest activity was exerted towards Pseudomonas 
aeruginosa (1.25/2.5 mg dm–3). 
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SAŽETAK  
Novi ureidoamidi iz aminokiselina: Sinteza i biološko djelovanje  
Ivana Perković,a Ivan Butula,a Zrinka Rajić,a Dimitra Hadjipavlou-Litina,b  
Eleni Pontikib i Branka Zorca  
aFaculty of Pharmacy and Biochemistry, University of Zagreb, HR-10000 Zagreb, Croatia  
bDepartment of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, 
Thessaloniki 54 124, Greece  
U radu je opisana sinteza novih aminokiselinskih ureidoamida 4a-o polazeći iz klorida N-(1-benzotriazolkarbonil)-
aminokiselina 3, derivata L-alanina, L-valina, L-leucina, D-fenilglicina i L-fenilalanina, i odgovarajućih 
aminoalkohola (2-amino-etan-1-ol, 3-amino-propan-1-ol i 5-amino-pentan-1-ol). Struktura spojeva potvrđena je 
uobičajenim spektroskopskim metodama (IR, 1H i 13C NMR) i elementarnom analizom. Antioksidativna 
ispitivanja pokazuju da sintetizirani spojevi posjeduju blago djelovanje (interakcija s 1,1-difenil-pikrilhidrazil 
radikalom, inhibicija lipoksigenaze iz soje, inhibicija peroksidacije linolne kiseline). Preliminarna citostatska 
ispitivanja na pet humanih staničnih linija i antimikrobna ispitivanja na nekoliko mikroorganizama pokazuju da 
sintetizirani ureidoamidi imaju slabo antiproliferativno, odnosno antimikrobno djelovanje.  
